Comparison of Aprotinin and Controlled Hypotension on Blood Loss in the Herniated Intervertebral Disc Surgery

Document Type : Original Article

Authors

1 Surgical Oncology Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, IR Iran

2 Faculty of Medicine, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, IR Iran

3 Education and Research Department, Razavi Hospital, Mashhad, IR Iran

Abstract

Background: Methods of reducing blood loss in surgical procedures such as spinal disc herniation, which are characterized by severe bleeding, can reduce the need for blood transfusion and thereby the risk of infectious diseases transmission, transfusion reactions, acute lung injury, graft-versus-host disease (GVHD), hypothermia, coagulation disorders and metabolic complications. Anti-fibrinolytic drugs (e.g. Aprotinin, aminocaproic acid, desmopressin and tranexamic acid) and controlled hypotension (monitored reduction by medication) are among these methods.
 
Objectives: In our clinical trial, two methods of aprotinin and controlled hypotension are compared in terms of their efficacy in reducing blood loss.
 
Patients and Methods: 70 patients undergoing spinal disc herniation were randomly divided into two groups of controlled hypotension (treated with nitroglycerin: starting with 5 µg/minute to reach an MAP of 55 - 60 mmHg, with an increase of 5 µg/minute of the drug in every 3 - 5 minutes) and aprotinin (0.5 million units injection before surgery). The anesthesia was administered similarly to both groups and blood pressure and heart rate were recorded every 5 to 15 minutes. Moreover, the amount of bleeding and the surgeon satisfaction were measured.
 
Results: 70 patients were identical in terms of demographics and the length of surgery. The two groups were not statistically different in terms of mean change in systolic, diastolic and mean blood pressure and heart rate at different times. The severity of blood loss measured on Boezarrt scale for low, medium and severe bleeding was respectively 21 (30%), 27 (39%), and 12 (31%). The extent of surgeon satisfaction with the operation room measured on a 3-point Likert scale (poor, medium and good) was 18 (26%), 40 (57%), and 12 (17%), respectively. The results were almost corresponding in both groups. Also, the two groups were identical in terms of calculated blood loss and the need for additional intraoperative medication.
 
Conclusions: In intervertebral herniated disc surgery, aprotinin and controlled hypotension treatments yielded similar results in terms of reducing blood loss and surgeon satisfaction with the field of operation.

Keywords

Open Access Policy: This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/

References

1. Mannucci PM, Levi M. Prevention and treatment of major blood loss. N Engl J Med. 2007;356(22):2301-11.
https://doi.org/10.1056/NEJMra067742
PMid:17538089
 
2. Esmaeelzadeh M, Amini S. The effect of tranexamic acide on cardiac surgery bleeding. Rev Clin Med. 2014;1(1):7-11.
 
3. Daly DJ, Myles PS, Smith JA, Knight JL, Clavisi O, Bain DL, et al. Anticoagulation, bleeding and blood transfusion practices in Australasian cardiac surgical practice. Anaesth Intensive Care. 2007;35(5):760-8.
https://doi.org/10.1177/0310057X0703500516
PMid:17933164
 
4. Rogers MA, Blumberg N, Saint SK, Kim C, Nallamothu BK, Langa KM. Allogeneic blood transfusions explain increased mortality in women after coronary artery bypass graft surgery. Am Heart J. 2006;152(6):1028-34.
https://doi.org/10.1016/j.ahj.2006.07.009
PMid:17161047
 
5. Murphy GJ, Reeves BC, Rogers CA, Rizvi SI, Culliford L, Angelini GD. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation. 2007;116(22):2544-52.
https://doi.org/10.1161/CIRCULATIONAHA.107.698977
PMid:17998460
 
6. McQuilten ZK, Andrianopoulos N, Wood EM, Cole-Sinclair MF, McNeil JJ, Cameron PA, et al. Transfusion practice varies widely in cardiac surgery: Results from a national registry. J Thorac Cardiovasc Surg. 2014;147(5):1684-1690 e1.
https://doi.org/10.1016/j.jtcvs.2013.10.051
PMid:24332109
 
7. Blajchman MA, Vamvakas EC. The continuing risk of transfusiontransmitted infections. N Engl J Med. 2006;355(13):1303-5.
https://doi.org/10.1056/NEJMp068178
PMid:17005947
 
8. Mannucci PM. Hemostatic drugs. N Engl J Med. 1998;339(4):245-53.
https://doi.org/10.1056/NEJM199807233390407
PMid:9673304
 
9. Lange M, Van Aken H, Westphal M. Prevention and treatment of major blood loss. N Engl J Med. 2007;357(12):1260.
https://doi.org/10.1056/NEJMc071849
 
10. Michelson AD, Barnard MR. Plasmin-induced redistribution of platelet glycoprotein Ib. Blood. 1990;76(10):2005-10.
https://doi.org/10.1182/blood.V76.10.2005.bloodjournal76102005
https://doi.org/10.1182/blood.V76.10.2005.2005
 
11. Larson A. Deliberate hypotension. Anesthesiology. 2009;25(1)
 
12. Pilli G, Guzeldemir ME, Bayhan N. Esmolol for hypotensive anesthesia in middle ear surgery. Acta Anaesthesiol Belg. 1996;47(2):85-91.
 
13. Degoute CS. Controlled hypotension: a guide to drug choice. Drugs. 2007;67(7):1053-76.
https://doi.org/10.2165/00003495-200767070-00007
PMid:17488147
 
14. Amaranath L, Kellermeyer WJ. Tachyphylaxis to sodium nitroprusside. Anesthesiology. 1976;44(4):345-8.
https://doi.org/10.1097/00000542-197604000-00016
PMid:1259195
 
15. van der Linden J, Lindvall G, Sartipy U. Aprotinin decreases postoperative bleeding and number of transfusions in patients on clopidogrel undergoing coronary artery bypass graft surgery: a double-blind, placebo-controlled, randomized clinical trial. Circulation. 2005;112(9 Suppl):I276-80.
https://doi.org/10.1161/CIRCULATIONAHA.104.524611
 
16. Lindvall G, Sartipy U, van der Linden J. Aprotinin reduces bleeding and blood product use in patients treated with clopidogrel before coronary artery bypass grafting. Ann Thorac Surg. 2005;80(3):922-7.
https://doi.org/10.1016/j.athoracsur.2005.03.079
PMid:16122456
 
17. Okubadejo GO, Bridwell KH, Lenke LG, Buchowski JM, Fang DD, Baldus CR, et al. Aprotinin may decrease blood loss in complex adult spinal deformity surgery, but it may also increase the risk of acute renal failure. Spine (Phila Pa 1976). 2007;32(20):2265-71.
https://doi.org/10.1097/BRS.0b013e31814ce9b0
PMid:17873821
 
18. Tayyab NA, Mariller MM, Rivlin M, Berekashvili K, Bitan FD, Casden AM, et al. Efficacy of aprotinin as a blood conservation technique for adult deformity spinal surgery: a retrospective study. Spine (Phila Pa 1976). 2008;33(16):1775-81.
https://doi.org/10.1097/BRS.0b013e31817b87c4
PMid:18628710
 
19. Bai SC, Wang JY, Qin GP. Combined using Aprotinin, Hemodilution andinduced Hypotention in patients undergoing eurosurgery. Acta Academiae Medicinae Neimongol. 2008;1:7.
 
20. Pleym H, Stenseth R, Wahba A, Bjella L, Karevold A, Dale O. Single-dose tranexamic acid reduces postoperative bleeding after coronary surgery in patients treated with aspirin until surgery. Anesthesia Analgesia. 2003;96(4):923-8.
https://doi.org/10.1213/01.ANE.0000054001.37346.03
PMid:12651635
 
21. Ker K, Edwards P, Perel P, Shakur H, Roberts I. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ. 2012;344:e3054.
https://doi.org/10.1136/bmj.e3054
PMid:22611164 PMCid:PMC3356857
Razavi International Journal of Medicine
Volume 3, Issue 3
July 2015
Pages 13-17

Files

Share

How to cite

Statistics